Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T08:37:34.320Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of Lactobacillus casei Shirota on immune function

Published online by Cambridge University Press:  04 June 2010

H. Dong ,
I. Rowland ,
K. M. Tuohy ,
L. V. Thomas  and
P. Yaqoob
H. Dong
Affiliation:
The University of Reading, Whiteknights, P.O. Box 226, Reading RG6 6AP, UK
I. Rowland
Affiliation:
The University of Reading, Whiteknights, P.O. Box 226, Reading RG6 6AP, UK
K. M. Tuohy
Affiliation:
The University of Reading, Whiteknights, P.O. Box 226, Reading RG6 6AP, UK
L. V. Thomas
Affiliation:
Yakult UK Ltd, Artemis, Odyssey Business Park, West End Road, Ruislip HA4 6QE, UK
P. Yaqoob
Affiliation:
The University of Reading, Whiteknights, P.O. Box 226, Reading RG6 6AP, UK
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 69 , Issue OCE3: 3rd Immunonutrition Workshop, 21–24 October 2009, Girona, Spain , 2010 , E243
Copyright
Copyright © The Authors 2009

Modulation of host immunity is an important potential mechanism by which probiotics confer health benefits. This study was designed to investigate the effects of a probiotic strain Lactobacillus casei Shirota (LcS) on immune function using human peripheral blood mononuclear cells (PBMC) in vitro. In addition, the role of monocytes in LcS-induced immunity was also explored.

Methods: PBMC were obtained from 5–19 healthy adults. LcS were grown anaerobically in MRS broth and harvested in the exponential phase. PBMC (1×106 cells/ml) were exposed to three different concentrations of viable LcS for 24 h with or without 2.5 μg/ml ConA. The activation markers, CD69 and CD25, on T cell subsets were assessed by flow cytometry. For measurement of cytokine production, PBMC were stimulated for 24 h by three different concentrations of viable LcS with or without 1 μg/ml LPS and cytokines were measured by ELISA. Natural killer (NK) cell activity stimulated by LcS at 106 CFU/ml was assessed by flow cytometry, using K562 cells as target cells. Monocytes were depleted from PBMC by magnetic beads. PBMC and monocyte-depleted PBMC were compared for their response to LcS-induced activation and cytokine production.

Results: In the absence of ConA, LcS-induced expression of both CD69 and CD25, in particular, on CD8+ T-cells (P<0.001). The maximal effect was seen with 106 CFU/ml, representing an LcS: PBMC ratio of 1:1. LcS alone induced production of IL-1β, IL-6, TNF-α, IL-12 and IL-10 (P<0.001). In the presence of LPS, LcS promoted IL-1β production, but inhibited LPS-induced IL-10 and IL-6 production, and had no further effect on TNF-α and IL-12 production. NK cell activity was greatly promoted by LcS. Monocyte-depletion significantly reduced the impact of LcS on lymphocyte activation and cytokine production.

Conclusions: LcS preferentially activates cytotoxic lymphocytes in both the innate and specific immune system, which suggests that LcS could potentiate the destruction of infected cells in the body. LcS also induces both pro-inflammatory and anti-inflammatory cytokine production in the absence of LPS, but inhibits LPS-induced cytokine production. Monocytes play an important role in LcS-induced immunological responses.

This research was sponsored by Dorothy Hodgkin Postgraduate Awards and Yakult UK.